Cathy OʼSullivan1, L Lee Dupuis, Lillian Sung. 1. aProgram in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning bDepartment of Pharmacy, The Hospital for Sick Children cLeslie Dan Faculty of Pharmacy, University of Toronto dDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: Children receiving chemotherapy experience a high burden of symptoms. The purposes of this review were to identify symptom assessment tools used in pediatric cancer patients published in the last year; describe the characteristics of the identified tools; and evaluate their appropriateness for symptom screening and to alter patient management. RECENT FINDINGS: We identified six different symptom screening or assessment tools used across 10 studies in the past year. Four instruments contained 30 or more items. Patient management was not altered on the basis of identified symptoms in any of these studies. SUMMARY: Symptom assessment in pediatric oncology continues to be an active area of study but the available instruments are not yet used to guide symptom management. Future research should focus on implementing active and ongoing symptom screening into clinical practice and determining if active symptom screening improves patient outcomes. Electronic symptom screening tools may improve the feasibility of incorporating symptom screening tools into routine practice.
PURPOSE OF REVIEW: Children receiving chemotherapy experience a high burden of symptoms. The purposes of this review were to identify symptom assessment tools used in pediatric cancerpatients published in the last year; describe the characteristics of the identified tools; and evaluate their appropriateness for symptom screening and to alter patient management. RECENT FINDINGS: We identified six different symptom screening or assessment tools used across 10 studies in the past year. Four instruments contained 30 or more items. Patient management was not altered on the basis of identified symptoms in any of these studies. SUMMARY: Symptom assessment in pediatric oncology continues to be an active area of study but the available instruments are not yet used to guide symptom management. Future research should focus on implementing active and ongoing symptom screening into clinical practice and determining if active symptom screening improves patient outcomes. Electronic symptom screening tools may improve the feasibility of incorporating symptom screening tools into routine practice.
Authors: Sasja A Schepers; Lotte Haverman; Sima Zadeh; Martha A Grootenhuis; Lori Wiener Journal: Pediatr Blood Cancer Date: 2016-08-11 Impact factor: 3.167
Authors: Donna L Johnston; Shannon Hyslop; Deborah Tomlinson; Christina Baggott; Paul Gibson; Andrea Orsey; David Dix; Vicky Price; Magimairajan Vanan; Carol Portwine; Susan Kuczynski; Brenda Spiegler; George A Tomlinson; Laura Lee Dupuis; Lillian Sung Journal: Cancer Med Date: 2018-03-23 Impact factor: 4.452
Authors: Deborah Tomlinson; Erin Plenert; Grace Dadzie; Robyn Loves; Sadie Cook; Tal Schechter; Jennifer Furtado; L Lee Dupuis; Lillian Sung Journal: Cancer Med Date: 2020-06-21 Impact factor: 4.452
Authors: L Lee Dupuis; Donna L Johnston; Christina Baggott; Shannon Hyslop; Deborah Tomlinson; Paul Gibson; Andrea Orsey; David Dix; Vicky Price; Magimairajan Vanan; Carol Portwine; Susan Kuczynski; Brenda Spiegler; George A Tomlinson; Lillian Sung Journal: J Natl Cancer Inst Date: 2018-06-01 Impact factor: 13.506